Latest Insider Transactions at Allscripts Healthcare Solutions, Inc. (MDRX)
This section provides a real-time view of insider transactions for Allscripts Healthcare Solutions, Inc. (MDRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-0.38%
|
$11,007
$9.61 P/Share
|
|
May 31
2024
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+33.29%
|
-
|
|
May 31
2024
|
Jonathan Judge |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+19.43%
|
-
|
|
May 31
2024
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+36.11%
|
-
|
|
May 31
2024
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,632
+30.51%
|
-
|
|
May 31
2024
|
Susan Rodriguez |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+50.0%
|
-
|
|
May 31
2024
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+35.16%
|
-
|
|
May 31
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,895
+32.24%
|
-
|
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,179
-7.57%
|
$55,611
$9.5 P/Share
|
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
21,053
+20.5%
|
-
|
|
May 31
2024
|
Leland Westerfield CFO |
BUY
Grant, award, or other acquisition
|
Direct |
105,264
+50.0%
|
-
|
|
May 31
2024
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
63,158
+16.39%
|
-
|
|
May 25
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-2.24%
|
$10,780
$7.55 P/Share
|
|
May 03
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,105
-2.97%
|
$14,735
$7.7 P/Share
|
|
May 03
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-1.21%
|
$22,183
$7.7 P/Share
|
|
May 02
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-1.08%
|
$13,251
$7.8 P/Share
|
|
May 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,354
-5.05%
|
$65,478
$7.82 P/Share
|
|
May 01
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.61%
|
$30,107
$7.82 P/Share
|
|
Apr 01
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.27%
|
$1,351
$7.8 P/Share
|
|
Apr 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,709
-1.51%
|
$39,963
$7.8 P/Share
|
|
Apr 01
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,304
+5.12%
|
-
|
|
Mar 02
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,884
-2.4%
|
$77,304
$6.13 P/Share
|
|
Mar 02
2024
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,982
+10.67%
|
-
|
|
Mar 01
2024
|
Stonehill Capital Management LLC |
BUY
Open market or private purchase
|
Indirect |
3,997,875
+15.8%
|
$23,987,250
$6.0 P/Share
|
|
Feb 29
2024
|
Stonehill Capital Management LLC |
BUY
Open market or private purchase
|
Indirect |
525,000
+2.99%
|
$3,150,000
$6.09 P/Share
|
|
Feb 28
2024
|
Stonehill Capital Management LLC |
BUY
Open market or private purchase
|
Indirect |
5,700,000
+25.65%
|
$34,200,000
$6.81 P/Share
|
|
Feb 26
2024
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,540
+30.93%
|
-
|
|
Feb 26
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
55,194
+23.4%
|
-
|
|
Feb 26
2024
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
37,847
+13.32%
|
-
|
|
Sep 03
2023
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-0.58%
|
$15,899
$13.52 P/Share
|
|
Aug 04
2023
|
Richard J. Poulton CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
162,271
-13.6%
|
$2,109,523
$13.5 P/Share
|
|
Aug 04
2023
|
Richard J. Poulton CEO |
BUY
Grant, award, or other acquisition
|
Direct |
366,302
+23.49%
|
-
|
|
May 25
2023
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,519
-3.76%
|
$16,709
$11.89 P/Share
|
|
May 10
2023
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-1.49%
|
$34,859
$11.9 P/Share
|
|
May 10
2023
|
Richard J. Poulton CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,205
-1.57%
|
$145,255
$11.9 P/Share
|
|
May 10
2023
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,353
-5.5%
|
$25,883
$11.9 P/Share
|
|
May 02
2023
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-1.49%
|
$22,716
$12.15 P/Share
|
|
May 02
2023
|
Leah Jones Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,223
-2.54%
|
$26,676
$12.15 P/Share
|
|
May 01
2023
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.98%
|
$51,612
$12.53 P/Share
|
|
May 01
2023
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,354
-6.84%
|
$112,248
$12.53 P/Share
|
|
May 01
2023
|
Leah Jones Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,866
-7.27%
|
$82,392
$12.53 P/Share
|
|
Apr 01
2023
|
Leah Jones Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,209
-4.08%
|
$106,717
$13.05 P/Share
|
|
Apr 01
2023
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,806
-3.35%
|
$192,478
$13.05 P/Share
|
|
Apr 01
2023
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,304
+6.37%
|
-
|
|
Apr 01
2023
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,563
-1.17%
|
$33,319
$13.05 P/Share
|
|
Apr 01
2023
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-0.53%
|
$2,977
$13.05 P/Share
|
|
Mar 02
2023
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-1.57%
|
$49,210
$14.36 P/Share
|
|
Mar 02
2023
|
Richard J. Poulton CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,351
-2.82%
|
$340,914
$14.36 P/Share
|
|
Feb 26
2023
|
Richard J. Poulton CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
171,465
-8.69%
|
$2,743,440
$16.85 P/Share
|
|
Feb 26
2023
|
Richard J. Poulton CEO |
BUY
Grant, award, or other acquisition
|
Direct |
366,302
+26.36%
|
-
|